These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 18386139)

  • 1. Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California.
    Parikh-Patel A; White RH; Allen M; Cress R
    Cancer Causes Control; 2008 Oct; 19(8):887-94. PubMed ID: 18386139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased cancer risk in patients with cutaneous lupus erythematosus and systemic lupus erythematosus compared with the general population: A Danish nationwide cohort study.
    Westermann R; Zobbe K; Cordtz R; Haugaard JH; Dreyer L
    Lupus; 2021 Apr; 30(5):752-761. PubMed ID: 33497306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort.
    Dreyer L; Faurschou M; Mogensen M; Jacobsen S
    Arthritis Rheum; 2011 Oct; 63(10):3032-7. PubMed ID: 21953088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer risk in systemic lupus: an updated international multi-centre cohort study.
    Bernatsky S; Ramsey-Goldman R; Labrecque J; Joseph L; Boivin JF; Petri M; Zoma A; Manzi S; Urowitz MB; Gladman D; Fortin PR; Ginzler E; Yelin E; Bae SC; Wallace DJ; Edworthy S; Jacobsen S; Gordon C; Dooley MA; Peschken CA; Hanly JG; Alarcón GS; Nived O; Ruiz-Irastorza G; Isenberg D; Rahman A; Witte T; Aranow C; Kamen DL; Steinsson K; Askanase A; Barr S; Criswell LA; Sturfelt G; Patel NM; Senécal JL; Zummer M; Pope JE; Ensworth S; El-Gabalawy H; McCarthy T; Dreyer L; Sibley J; St Pierre Y; Clarke AE
    J Autoimmun; 2013 May; 42():130-5. PubMed ID: 23410586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An international cohort study of cancer in systemic lupus erythematosus.
    Bernatsky S; Boivin JF; Joseph L; Rajan R; Zoma A; Manzi S; Ginzler E; Urowitz M; Gladman D; Fortin PR; Petri M; Edworthy S; Barr S; Gordon C; Bae SC; Sibley J; Isenberg D; Rahman A; Aranow C; Dooley MA; Steinsson K; Nived O; Sturfelt G; Alarcón G; Senécal JL; Zummer M; Hanly J; Ensworth S; Pope J; El-Gabalawy H; McCarthy T; St Pierre Y; Ramsey-Goldman R; Clarke A
    Arthritis Rheum; 2005 May; 52(5):1481-90. PubMed ID: 15880596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of cancer among rheumatoid arthritis patients in California.
    Parikh-Patel A; White RH; Allen M; Cress R
    Cancer Causes Control; 2009 Aug; 20(6):1001-10. PubMed ID: 19184473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased risk of malignancy in patients with systemic lupus erythematosus: population-based cohort study in Korea.
    Han JY; Kim H; Jung SY; Jang EJ; Cho SK; Sung YK
    Arthritis Res Ther; 2021 Oct; 23(1):270. PubMed ID: 34706772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung, liver, prostate, bladder malignancies risk in systemic lupus erythematosus: evidence from a meta-analysis.
    Ni J; Qiu LJ; Hu LF; Cen H; Zhang M; Wen PF; Wang XS; Pan HF; Ye DQ
    Lupus; 2014 Mar; 23(3):284-92. PubMed ID: 24429300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The age-risk relationship of haematologic malignancies in female patients with systemic lupus erythematosus: a nationwide retrospective cohort study.
    Lin YC; Yen JH; Chang SJ; Lin YC
    Lupus; 2012 Oct; 21(11):1250-6. PubMed ID: 22740427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased incidence of cancer in systemic lupus erythematosus: a Finnish cohort study with more than 25 years of follow-up.
    Tallbacka KR; Pettersson T; Pukkala E
    Scand J Rheumatol; 2018 Nov; 47(6):461-464. PubMed ID: 29318934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the safety profile of calcineurin inhibitors: cancer risk in patients with systemic lupus erythematosus from the LUNA registry-a historical cohort study.
    Ichinose K; Sato S; Igawa T; Okamoto M; Takatani A; Endo Y; Tsuji S; Shimizu T; Sumiyoshi R; Koga T; Kawashiri SY; Iwamoto N; Tamai M; Nakamura H; Origuchi T; Yajima N; Sada KE; Miyawaki Y; Yoshimi R; Shimojima Y; Ohno S; Kajiyama H; Sato S; Fujiwara M; Kawakami A
    Arthritis Res Ther; 2024 Feb; 26(1):48. PubMed ID: 38347556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of malignancy in an unselected cohort of Icelandic patients with systemic lupus erythematosus.
    Ragnarsson O; Gröndal G; Steinsson K
    Lupus; 2003; 12(9):687-91. PubMed ID: 14514131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal Dependence and Cancer in Systemic Lupus Erythematosus.
    Cobo-Ibáñez T; Urruticoechea-Arana A; Rúa-Figueroa I; Martín-Martínez MA; Ovalles-Bonilla JG; Galindo M; Calvo-Alén J; Olivé A; Fernández-Nebro A; Menor-Almagro R; Tomero E; Horcada L; Uriarte-Itzazelaia E; Martínez-Taboada VM; Andreu JL; Boteanu A; Narváez J; Bohorquez C; Montilla C; Santos G; Hernández-Cruz B; Vela P; Salgado E; Freire M; Hernández-Beriain JÁ; Díez-Álvarez E; Expósito L; Fernández-Berrizbeitia O; Velloso-Feijoo ML; Ibáñez-Barceló M; Lozano-Rivas N; Bonilla G; Moreno M; Raya E; Quevedo-Vila VE; Vázquez-Rodríguez TR; Ibáñez-Ruan J; Muñoz-Fernández S; Sánchez-Alonso F; Pego-Reigosa JM
    Arthritis Care Res (Hoboken); 2020 Feb; 72(2):216-224. PubMed ID: 31529686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of systemic lupus erythematosus autoantibody diversity with breast cancer protection.
    Shah AA; Igusa T; Goldman D; Li J; Casciola-Rosen L; Rosen A; Petri M
    Arthritis Res Ther; 2021 Feb; 23(1):64. PubMed ID: 33632283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignancy in Pediatric-onset Systemic Lupus Erythematosus.
    Bernatsky S; Clarke AE; Zahedi Niaki O; Labrecque J; Schanberg LE; Silverman ED; Hayward K; Imundo L; Brunner HI; Haines KA; Cron RQ; Oen K; Wagner-Weiner L; Rosenberg AM; O'Neil KM; Duffy CM; von Scheven E; Joseph L; Lee JL; Ramsey-Goldman R
    J Rheumatol; 2017 Oct; 44(10):1484-1486. PubMed ID: 28765255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic lupus erythematosus and the risk of malignancy.
    Cibere J; Sibley J; Haga M
    Lupus; 2001; 10(6):394-400. PubMed ID: 11434573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignancy in systemic lupus erythematosus.
    Abu-Shakra M; Gladman DD; Urowitz MB
    Arthritis Rheum; 1996 Jun; 39(6):1050-4. PubMed ID: 8651970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of cancer among female patients with systemic lupus erythematosus in Korea.
    Kang KY; Kim HO; Yoon HS; Lee J; Lee WC; Ko HJ; Ju JH; Cho CS; Kim HY; Park SH
    Clin Rheumatol; 2010 Apr; 29(4):381-8. PubMed ID: 20041274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus.
    Björnådal L; Löfström B; Yin L; Lundberg IE; Ekbom A
    Scand J Rheumatol; 2002; 31(2):66-71. PubMed ID: 12109649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.